Nureca Board Meeting Outcome

Nureca Results Update

Nureca reports Q2 FY27 revenue of ₹58.53 crore, up 55% YoY, its highest in 20 quarters. PAT rose 12% to ₹4.05 crore on broad-based growth across channels.

Nureca Q2 FY27 Results: Net Profit ₹4.1 Cr, Up 13.9% YoY

Nureca Ltd reported revenue from operations of ₹58.5 Cr (+55.2% YoY) and net profit of ₹4.1 Cr (+13.9% YoY) for Q2 FY27.

Key figure

Net profit ₹4.1 Cr · +13.9% YoY

Nureca Legal & Regulatory

Nureca Limited announces the closure of customs proceedings by the Commissioner of Customs, with a previously deposited ₹0.57 Crore appropriated to settle all related liabilities.

Value

₹0.57 Cr

Nureca Other Announcement

Nureca Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations. This filing provides public disclosure of stakes.

Nureca Board Meeting Date

Nureca Limited has scheduled a board meeting for October 21, 2026, to consider and approve the company's standalone and consolidated unaudited financial results.

Nureca Promoter Buying: ₹0.42 Cr

Nureca Limited promoter Saurabh Goyal acquired 11,368 equity shares through an open market purchase. This transaction increased the promoter's holding from 70.08% to 70.20%.

Value

₹0.42 Cr

Promoter stake change

+0.12%

R R Kabel Board Meeting Outcome

RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.

M K Exim (India) Board Meeting Outcome

M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.

United Spirits Board Meeting Outcome

United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.

SBI Funds Management Board Meeting Outcome

SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.

Execution

April 1, 2028 to March 31, 2030

Paras Healthcare Board Meeting Outcome

Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.

Gateway Distriparks Board Meeting Outcome

Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.